Please login to the form below

Research Partnership

Research Partnership : Global pharmaceutical market research
Research Partnership is one of the world’s largest independent healthcare market research and consulting agencies. We’re trusted by the global pharmaceutical industry to provide the intelligence they need to flourish in an environment that’s becoming ever more challenging.

We work solely in healthcare, where our expertise and passion are unparalleled. Because we are independent, we can provide a truly bespoke service, managed by our large and experienced senior team and supported by our talented pool of professionally-trained researchers.

What we deliver goes beyond research. Our clients see us as a valued partner working to resolve their business challenges, providing strategic recommendations and brand roadmaps to help them optimise their budgets and maximise their competitive edge.

Areas of Expertise

Using the full range of qualitative and quantitative techniques, we specialise in custom research and consultancy.

Prescription medicines
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.

Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients and consumers to deliver integrated insights.

Medical devices and diagnostics
Our experience covers everything from insulin pens to large-scale surgical systems. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.

From market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and tracking, we support pharma through the lifecycle of the brand.

Team

Mark Jeffery
Mark Jeffery
Founding Director
contact@researchpartnership.com
Mary Assimakopoulos
Mary Assimakopoulos
Founding Director
contact@researchpartnership.com
View LinkedIn profile
Harriet Kozak
Harriet Kozak
US President
harrietk@researchpartnership.com
Marc Yates
Marc Yates
Director, Emerging Markets
marcy@researchpartnership.com
View LinkedIn profile
 

White Papers and Resources

A safe place to talk about Crohn’s
Published in eyeforpharma April 2017 by Mariel Metcalfe
Patient Assistance Programme Evaluation for Cardiovascular Conditions
What next for the treatment of Psoriasis in Europe?
Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.
20 questions: Round 1
Brand tracking research
Pharma China Annual Forum 2017
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.
Healthcare Market Research in the Gulf: 3 lessons I’ve learned
A few key considerations for conducting healthcare market research in the Gulf
Case study: Multiple Sclerosis new medical device research
Patient Centricity: Turning Rhetoric into Reality
Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST
Live from Singapore: Understanding patient willingness to pay in emerging markets
Live webinar: Thursday 23rd March 16:00 SGT / 16:00 CST / 17:00 JST
Making sense of Nutraceuticals in China
Published in eyeforpharma February 2017 by Marc Yates
Research Partnership has been ranked in the Pharma Times Pharma Fast 50
Women's health in emerging markets
Research Partnership has published a new Living with Lupus (SLE) market report for 2017
SLE is a progressive and debilitating disease which affects 5 million people worldwide.
Cool heads in a crisis?
Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics
Biosimilars: Bringing patients into the conversation
Published in eyeforpharma January 2017 by Mariel Metcalfe
Access and elimination: the future of DAAs in hepatitis C
Published in Pharmaphorum January 2017
EphMRA One Day Meeting
We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London
Video: Segmentation research
Pharmaceutical Market Research Conference 2017
We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.
Shifting perceptions of the use of probiotics in IBS Management
Nutraceuticals in India: A Challenging Opportunity
Published in eyeforpharma December 2016 by Marc Yates
Research Partnership makes annual donation to Forever Projects
Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects
A Bitter Pill?
The ideal route of admin isn’t clear cut in the global marketplace
Understanding the chronic disease patient journey in emerging markets
Infographic: Keeping tracking on track
Our best practice approach to tracking studies.
Telehealth Research
The remote exchange of data between patients and their clinician
Case Study: Understanding the patient journey and addiction treatment pathways
Research Partnership has published a new Living with Chronic Pain market report for 2016
Nutraceuticals: Rich in Potential
Published in eyeforpharma October 2016 by Marc Yates
Case Study: Qualitative research with payers in low and middle income countries
Webinar - Immuno-oncology's Evolution: Implications for Pharma Market Researchers
In association with PMGroup
Case study: Leveraging Market Research Data to Inform Healthcare Providers and the Community
Towards a culture of evaluation and evidence-based decision making in global health
Reflections on THET Conference 2016: Evidence, Effectiveness & Impact
Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016
The Internet of Things
Evolution from man to machine
Therapy Watch expands its oncology portfolio
Time for a new language for asthma?
Evaluating the impact of your medical congress presence…more cost effectively
Delivering multi-stakeholder patient journey insights in oncology with creative outputs and data visualisation
Webinar: Understanding Patient Willingness to Pay
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?
Research Partnership welcomes 22 new Graduates
Case study: Tracking a product launch in a dynamic and competitive market
Understanding the Chronic Disease Patient Journey in Emerging Markets
Latest wave of Therapy Watch IBD to run this month
The IBD syndicated market tracker is part of our large auto-immune portfolio
Research Partnership launches new patient report - Living with Lupus (SLE)
Webinar: Ensuring an Actionable Segmentation
Interactive infographic: LATAM
An overview of the six most-commonly researched, largest pharma markets in Latin America
Immuno-oncology: The market opportunity for PD-1/PD-L1s
Case Study: Using ‘Journey to the Future’ projective techniques to understand evolving customer expectations
Free Thinking - US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare
Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcare
Therapy Watch market snapshots
Case Study: Private market opportunity for a travel vaccine
Infographic: Conference Live
Blog: The Cost of Counterfeits
The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.
Video: Self-pay and Emerging Markets
News: Therapy Watch HCV expands into 4 additional EU markets
News: Research Partnership launches new patient report - Living with Ulcerative Colitis
Summer Intern experience at Research Partnership
We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research
Beyond Andrology: Trends in Men’s Health in Emerging Markets
Published in eyeforpharma July 2016 by Rachel Howard
Infographic: HIV Market Snapshot
Infographic: The vaccine opportunity in Asia
Webinar: What next for biosimilars?
Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST
Understanding the Patient Journey
Case Study: Oncology diagnostic biomarker landscaping study
Research Partnership publishes 2016 Living with RA reports
Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016.
Article: The Art of Storytelling in Pharma Market Research
Published in PBIRG Perspective, May 2016, vol. 18 No.1, By Julie Denny, Marketing Director
Video: Immuno-oncology therapies
The challenges of conducting effective pharmaceutical market research in emerging markets
Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets
Research Partnership appoints Director and Head of Business Analytics, North America
Article: The Art of Storytelling in Pharma Market Research
Published in PBIRG Perspective, May 2016, vol. 18 No.1, By Julie Denny, Marketing Director
Event: EphMRA Annual Conference 2016
Frankfurt, Germany 21 - 23 June 2016
The challenges of conducting effective pharmaceutical market research in emerging markets
Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets
Blog: Viewing facility research, re-imagined
As technology has evolved, so too has the world of qualitative research
Video: Immuno-oncology therapies
Event: EULAR Annual European Congress of Rheumatology 2016
Forever Angels achievements and development plan for 2016
Research Partnership is proud to support Forever Angels in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania
The Opportunity for Women’s Health in Emerging Markets
Published in eyeforpharma April 2016 by Rachel Howard
Video: Storytelling in healthcare market research
Promotions and new appointments across our global offices
Research Partnership is delighted to announce promotions and new starters in the UK and further appointments in the US and Singapore offices
Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?
Webcast: Understanding the Chronic Disease Patient Journey in Emerging Markets
In emerging markets where primary care systems do not exist, the patient is the only constant in the journey
Living with Crohn's Report
Are you looking for a deeper understanding of the emotional needs, behaviours and treatment programmes of patients living with Crohn’s Disease?
Infographic: Research Partnership
Our latest infographic offers an overview of some key facts and figures about the company, its services and capabilities.
AAD conference 2016
Therapy Watch recently presented “real-world” patient data on treatment duration and persistence among European PsO patients
Video: Global Biosimilars Market
Research director of Therapy Watch, Laurent Chanroux, discusses the growth opportunities for biosimilars and the importance of adaptable market tracking for pre and post product launch
Case study: Understanding Patient Willingness to Pay in Emerging Markets
From promise to practice: immuno-oncology in action Part 3 - Emerging Markets
Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.
Infographic: HCV EU
Taiwan: Exploring the Healthcare Opportunity in this Singular “Hybrid” Market
Published in eyeforpharma February 2016 by Rachel Howard
Gaining deeper insights within a hard to reach audience
Living with RA Report
Living with Rheumatoid Arthritis 2016 is a new syndicated report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.
Heather Desmet appointed new Head of Living With
We are delighted to welcome Heather Desmet as Head of Living With at the company’s London headquarters.
Webinar Recording: The Art of Storytelling in Pharma Market Research
Video: Conducting mobile conference research
Our digital expert, Director John Branston explores how a mobile approach offers a better way of evaluating the impact of your conference presence
Free Thinking: From promise to practice: immuno-oncology in action
Video: Syndicated patient record data
Track the global market in real time
Video: Patient level prescribing decisions
Pharma Market Research Report - Predictions for 2016
PMR invited US President Harriet Kozak to submit her predictions for 2016
Pharmaceutical Market Research Conference 2016
Nicole Bender Moreira promoted to Associate Director, Singapore office
New appointments announced across Research Partnership’s global offices
We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters
What to Consider When Conducting Patient Research in Saudi Arabia
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
Research Partnership hires Graphic Designer to create storytelling deliverables
Research Partnership is UK’s fastest growing healthcare market research specialist
Emerging Markets: Your Essential Guide
Free Thinking: From promise to practice: immuno-oncology in action
Exploring the Opportunity For Halal In Healthcare
Published in Medical Marketing & Media November 2015
Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets
Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets
12 Challenges Big Pharma Faces in China
Published in eyeforpharma 16 November by Rachel Howard
Using mobile “diary” research to capture patient-generated insights in COPD
Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients
Biosimilars in 2018: EU doctors’ perceptions of RA drug market
Published in pharmaphorum October 2015 by Laurent Chanroux
Webinar: Understanding the Patient Journey in China 2015
Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.
Understanding Patient Willingness to Pay
Published in eyeforpharma 12 October by Rachel Howard
Infographic: Spondyloarthritis
Overview of spondyloarthritis patient profiles and treatment pathways.
Webinar: Demand assessment - Reflecting real world choices
How study design which reflects doctors’ real world choices can optimise results.
Evaluating the potential of a pre-launch prodct in a real-life setting
Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.
Competition from within
Published in eyeforpharma July 29 by Rachel Howard
Infographic: RA Perceptions
HCPs predict the future of the biologics market
From chaos to calm: how to make sense of social media
What do you know about chaos theory?
Could ‘around the pill’ solutions be the key to effective diabetes management?
Published in pharmaphorum July 2015 by Julie Denny
Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America
Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.
Infographic: HCV LATAM
An introduction to the HCV LATAM patient.
Spotlight on Saudi Arabia
Published in eyeforpharma 20 May by Rachel Howard
Infographic: North Asia
An overview of the five most-commonly researched, largest pharma markets in North Asia.
Infographic: PsO market snapshot
Infographic: Prostate Cancer Market Snapshot
Infographic: LATAM
Infographic: RA market snapshot
Infographic: CEE
Infographic: ASEAN-6
Infographic: HCV - The Roadblocks to Effective Treatment
Turkey: Identifying the Growth Drivers
Published in eye for pharma 3 April by Marc Yates
Article: The Patient Abroad
Published in Medical Marketing & Media March 2015
A guide to measuring and tracking brand KPIs
Dr Allison Fleetwood, Director of Therapy Watch, alongside Associate Director Jennifer Redfearn, recently delivered a workshop on measuring and tracking brand KPIs as part of the BHBIA training programme (www.bhbia.org.uk).
Electronic medical records and doctor/patient communication
View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.
Statistics and bikinis – 2 men united
I want to write today about 2 men that between them have reminded me of a fine line that we have to tread every time we analyse a dataset...
Eliminating Stigma: A consideration of the role the pharmaceutical industry can play
Fighting talk
One thing that grasps my interest is how society has adopted military style language when talking about cancer
Is MINT the next BRIC?
In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all poised for massive economic growth. Earlier this year, O’Neill came out of retirement to generate buzz about ‘MINT’ – that’s Mexico, Indonesia, Nigeria and Turkey to the uninitiated – as the next generation ‘ones to watch’ in the coming twenty years.
The healthcare market research themes for 2014
As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.
Big Data—a new player in the Healthcare Industry
Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.
Blog: Affordable Care Act
What does the future hold for the US pharma industry?
Webinar: How to conduct effective market research in emerging markets
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.
Webinar: Uncovering hidden insights into patient compliance
Webinar: The patient journey: Time to look beyond the physician?
Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.
Webinar: Ensuring an actionable segmentation
One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.
Webcast: Leveraging the ASEAN opportunities
Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.
Webcast: Biosimilars: Friend or Foe to Healthcare?
Understanding the opportunities for biosimilars and the threats to innovator biologics
Webinar: Understanding the patient journey in China
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers the possible implications for market researchers.
Webinar: Capturing "in-the-moment" patient and physician insights
Utilising the benefits of mobile technology
Webinar: Observational Research
Presenting a window on the world of your customer
Webinar: The Brazil Conundrum
Conducting research in one of the world's largest pharma markets
Webinar: Demand calibration: What's inside the black box?
The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been reached.
Free Thinking: Behavioural economics
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Article: The Colombia Conundrum
Published in eye for pharma 30 January by Marc Yates
Ageing in China: The Implications for Healthcare
Published in eye for pharma 12 December by Marc Yates
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?
Published in Eye for Pharma 10 November by Marc Yates
Exploring MINT: Part 4 - Turkey
In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Turkey.
Getting to grips with Russia’s healthcare market
As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't exist.
Exploring MINT: Part 3 - Nigeria
In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.
Exploring MINT: Part 2 - Indonesia
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with a focus on the impact of its planned roll-out of a universal healthcare system.
Free Thinking: Leveraging the ASEAN Market
If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to consider in deciding which markets to research.
Free Thinking: Biosimilars: Friend or foe to healthcare?
Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.
The Next Billion Patients
Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
Huge Untapped Growth Potential of ASEAN
Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
The Untapped Potential of ASEAN: The key growth factors
In part 2 of the ASEAN series, Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
Exploring MINT: Part 1 - Mexico
In the first of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Mexico.
The power of observation in gathering patient insights
Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding.
Market Insights Can Deliver a Better Patient Experience
Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding
Excellence in oncology: Developing an effective biomarker strategy
Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.
The cost of being a caregiver
There is now a concerted effort on the part of the leading pharma manufacturers to try to understand patient needs as much as the needs of physicians
Warehousing of HCV patients reaches new high
A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation of more efficacious and tolerable new therapies.
Brand leaders in RA will lose market share, predict rheumatologists
Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.
Patients in China: the Silent Stakeholder
This month Mary Assimakopoulos, talks about the issues around healthcare access for patients in China and highlights some of the adherence issues unique to the region.
Removing the Roadblocks to Effective Patient Treatment
How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from the patient research series “Living with chronic illness”.
Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis
Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards their standard of care.
Patient Compliance – Cracking that Big Nut!
In this month’s column we look at the issue of non-adherence, the risk of bias in adherence surveys and how a better understanding of true patient behavior is critical to improving compliance.
Comparing East vs West in Hep C Patient Understanding
In this month’s column we look at Hepatitis C and examine the differences (and similarities) between the causes of non-adherence in China and the US
The Difficulties of Living with Depression Don't End with the Illness Itself
This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.
Patient Power: Too Much of a Good Thing?
Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding
Barriers to Biologic Treatment - Is Injecting Such a Pain?
Mary Assimakopoulos examines a common yet often unaddressed patient concern – the very human fear of needles!
China's Chronic Disease Challenge
260 million people from mainland China now suffer from a chronic disease condition such as diabetes because of lifestyle factors including smoking, lack of exercise and a high-fat diet. Apart from the particularly high smoking rate, most other developed nations have similar risk profiles. Yet the World Health Organisation (W.H.O) reports that 85% of deaths each year in China are from chronic illness, significantly more than anywhere else in the developed world. Why is this?
Webinar: Mobile Research in Asia and Emerging Markets
Current statistics around mobile technology reveal that many physicians in Asia are now using smartphones, tablets and other mobile devices to assist them in their daily practices. In China alone,73% of physicians regularly use mobile devices to make clinical decisions. With use of three client case studies, this webinar looks at the benefits of conducting mobile research amongst physicians and patients in Asia and the emerging markets.
Webinar: Reinventing Conference Research Using Mobile Technology
With the use of a real-life customer case study, this short 15 min webinar recording will describe the opportunities presented by mobile technology in a conference setting and how this new methodological approach can offer a superior way of eliciting delegate insights
Webinar: Understanding the Patient Journey in Order to Influence Prescribing Decisions
Using real data, this webinar looks at the increasingly popular view that says we need to understand more about the patient and the relationship they have with their physicians in order to really influence prescribing decisions and improve outcomes.
Webinar: Focus on China: Conducting Research in the World’s Fastest Growing Pharma Market
This webinar looks to provide market research professionals with an overview of the Chinese healthcare market and provide participants with top tips for conducting relevant and effective market research in the region.
Webinar: Prescription Rationale: Physician Research via an iPhone App
This webinar explores the potential of using smartphone Apps as a platform for collecting detailed qualitative insights into physicians' decision rationale at the moment of prescription.
Maximising patient adherence by leveraging the patient/ physician/ pharma relationship
Director Marc Yates looks at the problem of patient compliance - can a better understanding of patient attitudes, needs and behaviours help pharma develop strategies to improve adherence?
Digital research in Asia
Director Marc Yates uses findings from a study conducted in six markets in Asia to explore how digital channels are being utilised by consumers and look at the digital opportunities for marketers.
Achieving customer centricity - Using immersion techniques to get closer to the pulse of the customer
Director Marc Yates discusses the importance of being customer-centric in the pharmaceutical industry and how immersion techniques in market research can help develop a better understanding of the customer.
The Mobile Revolution - Using mobile Apps to deliver “in-the-moment” market research to global healthcare
Director John Branston investigates the use of mobile research in order to capture immediate detailed, qualitative insights into prescription rationale at the patient level.

Latest Tweets

Facebook

Testimonials

http://www.researchpartnership.com/who-we-are/-satisfaction/

"The team did an excellent job designing, executing, and synthesizing the data & insights from this study. It was a challenging project involving a large number of countries and in the end the team put together very thorough reports and a concise summary. The input during the design of the quant survey was also very valuable and ensured the right type of data was collected." 
Director, Commercial Planning & Operations

"I just want to thank you for the recent project you ran very successfully. The report delivered was high quality, definitely bringing new insights and ways to look at our marketing issue. It was also clear at the presentation that you had a deep understanding of the disease area. Very good job!" 
Director, Business Analysis

"Your results have driven key decision making which is now translating into very good performance for our brand, so well done." 
Commercial Analysis Manager

"I would like to thank all of you for the excellent work you did and all the support provided. Your expertise and professionalism was highly appreciated, as were the provided results. I’m already looking forward to the next possibility to work with you" 
International Business Analyst

"I just wanted to tell you how impressed I continue to be with the team at Research Partnership. They never seem to tire, take copious notes and remain engaged each and every day. It has certainly been a pleasure working with the team and I look forward to a continued partnership!" 
Associate Director, Global Marketing Science 

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

A safe place to talk about Crohn’s
Published in eyeforpharma April 2017 by Mariel Metcalfe
Research Partnership
Patient Assistance Programme Evaluation for Cardiovascular Conditions

Research Partnership
What next for the treatment of Psoriasis in Europe?
Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.
Research Partnership
20 questions: Round 1

Research Partnership
Brand tracking research

Research Partnership
Pharma China Annual Forum 2017
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.
Research Partnership